Malard, F., Sanz, J., Mediavilla, C., Lopez-Corral, L., Schauwvlieghe, A., Bernard, M., Loschi, M., François, S., Bonifazi, F., Heidenreich, D., Bruelle, M., Masouleh, B. K., Plantamura, E., Holler, E., Mohty, M. (2025). MaaT013 for ruxolitinib-refractory acute graft-versus-host disease with gastrointestinal involvement: Results from the ARES phase III trial. Blood. https://doi.org/10.1182/blood-2025-817